Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Market Cap : $0.42 Mil (As of Jun. 16, 2024)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Skystar Bio-Pharmaceutical Co's share price for the quarter that ended in Sep. 2014 was $4.19. Skystar Bio-Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2014 was 8.50 Mil. Therefore, Skystar Bio-Pharmaceutical Co's market cap for the quarter that ended in Sep. 2014 was $35.61 Mil.

Skystar Bio-Pharmaceutical Co's quarterly market cap increased from Mar. 2014 ($49.89 Mil) to Jun. 2014 ($55.82 Mil) but then declined from Jun. 2014 ($55.82 Mil) to Sep. 2014 ($35.61 Mil).

Skystar Bio-Pharmaceutical Co's annual market cap declined from Dec. 2011 ($19.62 Mil) to Dec. 2012 ($12.17 Mil) but then increased from Dec. 2012 ($12.17 Mil) to Dec. 2013 ($26.70 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Skystar Bio-Pharmaceutical Co's Enterprise Value for Today is $0.42 Mil.

Skystar Bio-Pharmaceutical Co Market Cap Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Market Cap Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Market Cap

Get a 7-Day Free Trial

70.60

69.69

19.62

12.17

26.70

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Market Cap	Get a 7-Day Free Trial															44.49	26.70	49.89	55.82	35.61

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Market Cap

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skystar Bio-Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Market Cap falls into.

Skystar Bio-Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Skystar Bio-Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2013 is calculated as

Market Cap (A: Dec. 2013 )	=	Share Price (A: Dec. 2013 )	*	Shares Outstanding (EOP) (A: Dec. 2013 )
	=	$3.511	*	7.6048
	=	$26.70

Skystar Bio-Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2014 is calculated as

Market Cap (Q: Sep. 2014 )	=	Share Price (Q: Sep. 2014 )	*	Shares Outstanding (EOP) (Q: Sep. 2014 )
	=	$4.19	*	8.49931
	=	$35.61

Skystar Bio-Pharmaceutical Co (GREY:SKBI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Skystar Bio-Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Market Cap

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines